Belite Bio Inc. - ADRBLTE
13F holders, Q2 2024 (June 30)11holders
2new positions
2sold out
1famous investor
$45.68avg. 13F price*
At the end of Q2 2024, 11 institutions reported holding Belite Bio Inc. - ADR (BLTE) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($6.8M), State Street Corp. ($716K) and Point72 Asset Management ($334K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Belite Bio Inc. - ADR
- CUSIP
- 07782B104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $7.0M |
| Exits | 2 | $590K |
All 13F filers, Q1 2024 → Q2 2024: 153,606 shares bought and 25,150 shares sold, net +128,456 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Armistice Capital, LLC | 0.18% | New | 148,000 | $6.8M |
| State Street Corp. | 0.00% | Reduce -6.0% | 15,671 | $716K |
| Point72 Asset Management | 0.00% | Reduce -16.0% | 7,311 | $334K |
| Geode Capital Management, LLC | 0.00% | No change | 6,700 | $306K |
| HRT Financial LP | 0.00% | New | 5,409 | $247K |
| Virtus Advisers, LLC | 0.04% | Reduce -7.8% | 1,807 | $83K |
| Morgan Stanley | 0.00% | Reduce -82.9% | 1,044 | $48K |
| GAMMA Investing LLC | 0.00% | Add +82.9% | 428 | $20K |
| Bank of America Corp. | 0.00% | Reduce -94.1% | 102 | $5K |
| JPMorgan Chase & Co. | 0.00% | Reduce -86.6% | 88 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +60.0% | 8 | $365 |
"% of holder's portfolio" is BLTE's weight in each manager's 13F, not the share of Belite Bio Inc. - ADR the manager owns.